Select Page
Home » Expert Content » Development & Bioavailability » Mitigating Risks During Preclinical Development

Mitigating Risks During Preclinical Development

Summary: In this video series, P.Y. Chen, Ph.D., of Catalent Pharma Solutions offers insights for accelerating early drug development and mitigating risk. An expert’s view on various tools available to mitigate risks during preclinical development in pharma.